On 5 July 2023, the European Commission issued a proposal for the regulation that intends to relax the requirements for marketing authorisation of plants obtained by certain new genomic techniques (NGTs) in the EU. While NGTs are expected to become more appealing to breeders and farmers, the complexity of the intellectual property (IP) landscape surrounding NGTs and resulting products can have a discouraging effect on innovation. In view of numerous concerns related to IP protection for NGTs and NGT-derived plants, a research group at the Institute has developed a set of policy recommendations that can facilitate access to and utilisation of IP-protected NGTs and their products in the plant breeding sector.
More on this topic:
CRISPR/Cas Technology and Innovation: Mapping Patent Law Issues